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Abstract—Glucometers present an important self-monitoring
tool for diabetes patients and therefore must exhibit high accu-
racy as well as good usability features. Based on an invasive,
photometric measurement principle that drastically reduces the
volume of the blood sample needed from the patient, we present
a framework that is capable of dealing with small blood samples,
while maintaining the required accuracy. The framework consists
of two major parts: 1) image segmentation; and 2) convergence
detection. Step 1) is based on iterative mode-seeking methods
to estimate the intensity value of the region of interest. We
present several variations of these methods and give theoretical
proofs of their convergence. Our approach is able to deal with
changes in the number and position of clusters without any
prior knowledge. Furthermore, we propose a method based on
sparse approximation to decrease the computational load, while
maintaining accuracy. Step 2) is achieved by employing temporal
tracking and prediction, herewith decreasing the measurement
time, and, thus, improving usability. Our framework is tested
on several real data sets with different characteristics. We show
that we are able to estimate the underlying glucose concentration
from much smaller blood samples than is currently state-of-the-
art with sufficient accuracy according to the most recent ISO
standards and reduce measurement time significantly compared
to state-of-the-art methods.
Index Terms—Blood glucose measurement, clustering, image
segmentation, kinetic modelling, mean-shift
I. INTRODUCTION
D IABETES MELLITUS describes a group of metabolicdiseases, affecting 347 million people worldwide. It
occurs when the pancreas cannot produce enough insulin
or when the body cannot use the insulin it produces [1].
The healthy glucose range lies between 70mg/dlto180mg/dl
[2]. A condition termed hypoglycaemia occurs when the
blood sugar level drops below 70mg/dl. This condition is
associated with a high short-term risk. Hyperglycaemia, in
contrast, occurs for blood sugar levels above 200mg/dl and
has longer-term effects on the body functions. Several studies
have been able to statistically associate a significant delay of
the onset, or slowing down the progression of complications
through intensive treatment guided by frequent blood glucose
self-monitoring [3], [4]. For this purpose, hand-held invasive
devices containing glucose biosensors are used by patients
to regularly and reliably self-monitor their glucose levels.
This typically requires to extract a blood sample from the
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patient’s finger using a lancet up to 4− 5 times daily and can,
therefore, present a hurdle to regular self-control. To reduce
the inhibition and pain threshold for the patient, we present
a framework based on a novel approach that uses a blood
sample in the nano litre-range (nl-range), which is up to a
magnitude of 100 smaller than is common in current state-of-
the-art devices [5], [6], hereby drastically reducing the pain
sensation for the patient.
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Fig. 1: The photometric measurement principle used to mea-
sure the glucose concentration in a blood sample.
The approach used in our work, illustrated in Fig. 1, is based
on a photometric measurement principle, where the blood
sample is placed on a chemical test strip that reacts with the
blood glucose, resulting in a color change. By illuminating
the test area and capturing the reflections, the color change
can be measured and associated with the underlying glucose
level. To counter the common problem of ambient light noise
[7] in photometry, the measurement area is placed completely
inside the device, and thus protected from ambient light. In
this approach the blood sample, and thus the region where the
reaction takes place, is very small compared to the chemical
test strip. The whole test strip is observed by an image sensor
resulting in frames at discrete time instants n = n0, n1, . . .
where n = tfs, t ∈ R being the continuous time and fs
is the sampling frequency. The frames show both the region
where the reaction takes place as well as surrounding areas.
The former represents the region of interest (ROI) and has
to be extracted. The underlying intensity value representing
2the color change is termed relative remission r ∈ R, which
is, finally, mapped to the underlying glucose concentration
g ∈ R. This process is carried out for the whole duration
of the chemical reaction, producing a set of frames. Typically,
the chemical reaction exhibits three different stages:
1) Constant relative remission where the reaction between
the glucose and the chemical agent has not started.
2) The moistening period starts at n = nD and is charac-
terised by a rapid drop of the relative remission value rD
followed by a slow decrease, which can be modelled by
an exponential decay.
3) Convergence is reached when the chemical reaction sat-
urates at n = nC at a converged remission value rC .
Figure 2 depicts an idealised course of a typical chemical
reaction for a low and a high glucose case. Different
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Fig. 2: The typical course of relative remission r over time,
termed kinetic curve, for a low (blue solid) and a high (green
dashed) glucose level. The three distinct stages of the chemical
reaction are illustrated.
behaviours of the frames can be observed depending on the
stage and the underlying glucose concentration. Figures 3 (a)
and 3 (d) show that frames captured before the chemical
reaction starts are characterised by a constant intensity over the
whole region. With the onset of the chemical reaction, the ROI
starts to shift in the direction of lower intensity. Depending
on the underlying glucose concentration, the intensity will
converge to a different final relative remission value rC . For
the low glucose range (Figs. 3 (b) and 3 (e)), this can be
very close to the initial reflectance behaviour of the constant
stage (n < nD), whereas for high glucose concentrations
(Figs. 3 (c) and 3 (f)) at least three distinct areas can typically
be identified. The ROI itself is best recognisable as the area
between the dotted lines in Fig. 3 (c). It is characterised by
a granular structure. Furthermore, we observe a thick edge
between the ROI and the background that takes on values
that lie in between both areas. In Fig. 3 (c), it is the area
between the solid and the dotted line. This occurs due to
the inhomogeneous distribution of the blood sample over the
edges, such that a weaker reaction takes place in this area. As
the images are often degraded by noise, it can be difficult to
distinguish the ROI from the other image regions, particularly
in low-contrast cases. The position of the ROI is unknown,
as it depends on the blood flow over the test strip, as well
as movements of the test strip in the camera field. Moreover,
the ROI is often disturbed by artefacts such as air bubbles or
dust particles that can change their position, size, and shape
during the reaction. The result of this is a change in the number
and position of clusters in the image over time as well as for
different glucose concentrations.
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Fig. 3: Examples of observed images and their respective
histograms. (a) and (d) show an observation at n < nD, (b)
and (e) show an observation of a low glucose measurement at
n > nC , (c) and (f) show an observation of a high glucose
measurement at n > nC .
The main contribution of this work is the development of
a framework to measure the concentration of an analyte in
a fluid from an image-based measurement procedure; in our
case the glucose concentration in blood. It is noteworthy, that
this framework is not confined to this sole application but is
suitable for other medical applications that rely on photometry.
We show that our framework exhibits high accuracy, while
reducing the blood sample volume from the micro litre-range
(µl-range) to the nl-range. The proposed methodology entails:
(i) the detection of the onset of the chemical reaction, using a
Neyman-Pearson hypothesis test; (ii) the segmentation of the
region of interest and accurate estimation of the underlying rel-
ative remission value for each incoming frame at time instant
n = nD, . . . , nC without prior knowledge on the number or
shape of the regions. We build up on our previous work in [8],
[9], by incorporating the median instead of the mean which
exhibits better performance, as well as, providing convergence
proofs for all the derived methods. Furthermore, a data-driven
heuristic is introduced to choose the subset size individually
for the scalable version, which further reduces the subset size
in most cases; (iii) the derivation of a model for the chemical
kinetics that is incorporated in a temporal tracking and pre-
diction setup to enhance accuracy and reduce measurement
time drastically; (iv) the mapping of the estimated remission
to the underlying glucose concentration. The validation of our
proposed framework is performed on an extensive collection
of real data sets taken in six different scenarios to ensure
robustness of the framework in different settings. Using these
sets, we are able to identify a minimum range for the blood
sample volume to maintain the required accuracy. We note that
3some aspects of this work appeared in [8], [9] and [10], while
the substantial part of this manuscript is novel.
Some notation: In this work, scalars are represented by lower
case, non-bold letters a, while lower case bold letters denote
vectors a and al indicates the l-th element of the vector.
Capital bold letters are matrices A and constants are given
by capital non-bold letters A. We denote estimates by aˆ and
sets by A. The use of n in the superscript denotes time indices
a(n) and j in the superscript denotes iteration steps a(j).
The paper is organised as follows: In Section II we discuss the
state-of-the-art. Section III presents the proposed framework,
detailing the different challenges and stages of the procedure.
It includes proofs of convergence of the proposed weighted
mean-shift and medoid-shift algorithms. Section IV introduces
the used data sets as well as the validation criteria. The
main part of this section comprises the experiments and the
discussion thereof. We conclude with a summary and an
overview on future work in Section V.
II. STATE-OF-THE-ART
Traditionally, glucose self-monitoring devices are based on
an invasive procedure that uses a photometric or an electro-
chemical approach to infer the glucose concentration from
the blood sample [6], [11], [12]. This requires the extraction
of a blood volume of 1 µlto25 µl. While much research is
being performed to replace the current devices by non-invasive
alternatives [13]–[15], it seems that the traditional technologies
will continue to maintain their position [6], at least in the
near future. Reducing the blood volume needed, and hereby
the induced pain remains a necessary field of research [6].
Traditional photometric measurement principles use a blood
sample in the µl-range that completely covers up the test field.
A photodiode is applied to capture the resulting reflections
[16]. The use of much smaller blood samples renders this
approach inaccurate, as the ROI becomes much smaller and the
signal-to-noise-ratio rises. This motivates the use of a camera
to observe the chemical reaction. To the best of our knowledge,
the problem of measuring blood glucose using the setup in
Fig.1 and an image processing-based approach has only been
tackled in a limited number of studies. In [5], the authors
propose to use a histogram-based approach and the setup in
Fig. 1 to estimate the intensity of the region of interest. To
this end, two clusters are assumed, one corresponding to the
ROI and the other to the background. The authors propose
to measure the displacement of the ROI cluster w.r.t. the
background cluster. The underlying assumptions are that just
two clusters exist in the image and that the background cluster
exhibits a constant relative remission value over time. These
are rather strong assumptions, which are hardly fulfilled in
practice. Our observations give evidence to a variable number
of clusters in the images, as seen in Fig. 3. The variability is
glucose level-specific, temporally dependent, and caused by
the variability of the chemical reaction for different blood
samples of different patients. Furthermore, the background
cluster does not experience a constant intensity but changes
over time due to temperature and humidity issues, as well
as leakage of small amounts of blood to the background
cluster. We assume that the number of clusters in the images
is unknown and propose an approach that is able to deal
systematically with this.
III. PROPOSED ALGORITHM
Our framework is summarised in Fig. 4. The input is
given by the frames obtained by the camera, representing the
reflectivity behaviour of the observed area. Each incoming
frame is directly processed. A hypothesis test is performed on
the pre-processed, gray-scale reflectance image X(n) of size
Mx×My, obtained at frame n, to detect whether the chemical
reaction has started, i.e., if n ≥ nD. In this case, we proceed
by segmenting the region of interest. After segmenting the
image, the relative remission values of the different regions
are estimated and the converged relative remission value rˆC
corresponding to the ROI is identified. The current estimate
along with the history of estimates is used to test for con-
vergence of the chemical reaction. If convergence is detected,
the underlying intensity value is mapped to its corresponding
glucose level gˆ. If not, the next frame is processed in the
same manner. The different blocks as depicted in Fig. 4 will
be described in further detail in the sequel.
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Fig. 4: The proposed approach.
A. Pre-processing
The raw framesX(n)raw obtained by the camera are normalised
w.r.t. the initial reflectivity prior to the start of the chemical
reaction. The normalisation is performed using the calibration
frames as described in [8] and results in a gray-level image
X
(n)
norm with pixels in the range between 0− 100.
In our previous work [8] we asserted that windowing the im-
ages results in superior segmentation and remission estimation
results. We termed this process binning and used B to denote
the size of the window. Binning is used as the last step in
the pre-processing stage unless stated otherwise. Finally, the
pre-processed image is denoted by X(n).
B. Detection of Drop Time
As illustrated in Fig. 2, the chemical reaction exhibits a
constant stage for n < nD, where the glucose in the blood
sample has not yet been detected. The time nD when the drop
occurs, i.e., when the chemical reaction starts, is dependent
on the particular chemical reagent, the blood sample at hand,
4and the underlying temperature and humidity conditions in the
device. We suggest using the Neyman-Pearson hypothesis test
of variance to detect nD . The advantage of using the Neyman-
Pearson test is that it provides a meaningful way to set a
threshold by incorporating the image statistics and controlling
the false-alarm rate. Figure 5 illustrates the probability density
functions fx˜ of the intensities of two exemplary images taken
at time n1 < nD and nC > n2 > nD, i.e., directly after
the occurrence of the drop. Extensive analysis of real data
showed that it is reasonable to assume that the mean-adjusted
frames for n < nD follow a zero-mean normal distribution
with variance σ21 , whereas after the drop the mean-adjusted
frames can be modelled by a zero-mean normal distribution
with variance σ22 > σ21 . This increase in variance can be
explained by the onset of the chemical reaction and thereby
the onset of the color change on the test strip. Hereby, σ21
can be estimated as the sample variance from available data
sets. However, σ22 is unknown and depends on the underlying
glucose concentration.
For the remainder of this work, we will deal with vectorised
forms of the images and denote these by
x
(n) = vec
(
X
(n)
)
, (1)
where x(n) is of size 1×L,L =Mx ·My. Now, the hypothesis
test can be formulated as
H0 :fx˜(n) ∼ N (0, σ
2
1), n < nD (2)
H1 :fx˜(n) ∼ N (0, σ
2
2), n ≥ nD
where x˜(n) is the mean-adjusted version of x(n) and f
x˜
(n)
denotes the pdf of x˜(n). Calculating the likelihood-ratio leads
to the following test statistic
T
(
x˜
(n)
)
=
L∑
l=1
(
x˜
(n)
l
)2 H1
≷
H0
L
2
L ln(δ) + ln(
σ22
σ21
)
1
σ21
− 1
σ22︸ ︷︷ ︸
δ′
, (3)
where the threshold δ is set to ensure a nominal false alarm
rate. Assuming x˜(n) to be spatially i.i.d., the distribution of
T(x˜(n))
σ21
underH0 and T(x˜
(n))
σ22
underH1 can be shown to follow
a χ2-distribution with L degrees of freedom [17]. The spatial
i.i.d. assumption is justifiable in our case as we are observing
frames prior to the onset of the reaction where no structure is
present in the image. L represents the number of pixels in an
image and is, therefore, quite large. Thus, we can approximate
the χ2-distribution by a Gaussian distribution [17] and the
probability of false alarm PFA becomes
PFA = Q
(
δ′
σ21
)
, (4)
where Q(·) is the complementary cumulative distribution
function of the standard Gaussian distribution. Given a fixed
probability of false alarm PFA, the threshold can be calculated
as δ′ = Q−1(PFA) · σ21 .
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Fig. 5: Pdf estimate of mean-adjusted intensities of a frame at
n1 < nD (blue solid) and n2 ≥ nD (green dashed).
C. Segmentation Using the Mean-Shift Algorithm
1) The Standard Mean-Shift Algorithm: Our underlying
assumption is that the glucose images will contain a ROI,
where the blood sample is distributed and, thus, the color
change of the ROI represents the reflectivity caused by the un-
derlying glucose concentration. This area will not necessarily
be completely spatially connected as it may contain artefacts
where the reaction has not taken place, or granularities in the
chemical that do not contribute to a proper reaction. Other
areas in the image will not correspond to the ROI, either,
because the blood sample is unevenly distributed in these
areas, or because the areas are dry, i.e., not covered with
blood. We interpret the different areas contained in the image
as clusters with specific cluster centres overlaid by noise.
We assume that data points converging to a certain cluster
center will belong to the corresponding area. The noise here
is assumed to be Gaussian. This assumption is based on the
calibration frames where no reaction has started.
The mean-shift algorithm [18] has become a popular approach
for clustering and mode location estimation. It has been widely
applied for medical image segmentation as it does not require
the knowledge of the actual number of clusters [8], [19]–
[22]. We use the mean-shift algorithm (MS), as well as two
extensions of it: the robust mean-shift (R-MS) [9] and the
scalable, sparse mean-shift (SS-MS) [10]. Furthermore, we
extend these variants to the medoid-shift [23].
Assume a set of L pixels in a gray-scale image1 at frame n that
can be expressed as x(n)l ∈ R, l = 1, . . . , L as in Eq. (1). We
will omit the frame notation, henceforth, for better readability.
A consistent estimator of the density is given by the kernel
density estimator (KDE) [24] with bandwidth parameter h
fˆK(x) =
1
Lh
L∑
l=1
K
(
x− xl
h
)
, (5)
where K(x) is a radially symmetric kernel function with a
strictly decreasing profile for x ≥ 0. The bandwidth h of the
kernel function is the only parameter that has to be tuned and
is crucial to the performance of the mean-shift algorithm, as it
affects the number of clusters. Extensive work has dealt with
the choice of the bandwidth parameter, e.g. [24], [25].
Generally, the mean-shift algorithm is derived by taking the
1Including spatial information for gray-scale images will increase
the dimensions by two, leading to a three-dimensional data vector
x = [xintensity, xposition,Mx , xposition,My ].
5zeros of the gradient of the KDE
∇fˆK(x) = 0 (6)
and reformulating to get the mean-shift vector of x as
m
(MS)
h,K′ (x) =
[∑L
l=1 xlK
′
(
x−xl
h
)∑L
l=1K
′
(
x−xl
h
) − x] , (7)
where K ′ = dKdx . Each data point is shifted according to
Eq. (7) in the direction of steepest ascent until convergence,
such that the sequence of successive locations of a data vector
x
(j+1) =
∑Ll=1 xlK ′
(
x
(j)−xl
h
)
∑L
l=1K
′
(
x
(j)−xl
h
)
 , j = 1, 2, ... (8)
where x(j) denotes the j-th iteration step. Typically, the mean-
shift algorithm tends to overestimate the number of modes. It
is usual to post-process the mean-shift results with a simple
clustering method to group nearby modes together, e.g. using
a mode pruning step with bandwidth h [8], [19].
Another way to express the KDE, which allows for extensions
of the mean-shift, is to consider the kernel to be an inner
product in the Hilbert space H, such that [26]
K
(
x− xl
h
)
= 〈Φ(x),Φ(xl)〉, (9)
where Φ : R → H is a mapping function and 〈·〉 denotes the
inner product. K(x−xlh ) is a positive definite kernel function.
Hence, the KDE can be formulated as
fˆ(x) = 〈Φ(x),
L∑
l=1
wlΦ(xl)〉. (10)
In this formulation, the uniform weights 1L have been substi-
tuted by wl > 0 to attain a more general form. It has been
shown [19] that the mean-shift algorithm converges and that
the mode estimator is asymptotically consistent and unbiased.
2) The Robust Mean-Shift Algorithm: In [9], the robust
mean-shift (R-MS) is derived as an alternative to account
for heavy-tailed noise in the data. Here, the sample mean of
vectors in Eq. (10) is substituted by a robust M-estimate
µˆΦ = argmin
µΦ
L∑
l=1
ρ
(
Φ(xl)− µΦ
σˆ
)
, (11)
where ρ(·) is a monotone, differentiable loss function, such as
Huber’s loss function [27] and the scale σˆ is initialized with
a robust estimate based on the mean absolute deviation [9].
This leads to the robust KDE
fˆ(x) = 〈Φ(x), µˆΦ〉 =
〈
Φ(x),
L∑
l=1
wR-MSl Φ(xl)
〉
=
1
h
L∑
l=1
wR-MSl K
(
x− xl
h
)
, (12)
where the robust weights wR-MSl can be determined using Itera-
tively ReWeighted Least Squares (IRWLS) [9], [28], resulting
in
wl =
 σˆ·ψ
(
Φ(xl)−µΦ
σˆ
)
Φ(xl)−µΦ
if Φ(xl)−µΦσˆ 6= 0
ψ′(0) if Φ(xl)−µΦσˆ = 0
, (13)
where ψ = ρ′. The robust mean-shift vector reads
m
(R-MS)
h,K′ (x) =
[∑L
l=1 w
R-MS
l xlK
′
(
x−xl
h
)∑L
l=1 w
R-MS
l K
′
(
x−xl
h
) − x] . (14)
For a more detailed description of the R-MS the reader is
referred to [9].
3) The Scalable Sparse Mean-Shift Algorithm: The compu-
tational complexity of the mean-shift algorithm is proportional
to the square of the total number of data points L. To overcome
the problem of high computational demand, a scalable sparse
version has been derived in [10]. A more detailed discussion
of the computational complexity of both versions is provided
in [10]. Using only a subset of the data points, the SS-MS is
able to achieve high accuracy while reducing computational
power. The gist lies in substituting the mean in Eq. (10) by a
sparse approximation [29], [30]. A short outline will be given
in the sequel, for more details the reader is referred to [10].
The sparse approximation of the mean can be formulated as
min
I|I|=N
min
αi,i∈I
∣∣∣∣∣
∣∣∣∣∣
L∑
l=1
wl〈Φ(x),Φ(xl)〉 −
∑
i∈I
αi〈Φ(x),Φ(xi)〉
∣∣∣∣∣
∣∣∣∣∣
2
.
(15)
where the index set I ⊆ {1, . . . , L} of cardinality |I| = N is
defined to be a subset of the full set of indices, the weights
follow α ∈ RN and 1 ≤ N ≪ L. The scalable, sparse KDE
fˆK(x) =
1
h
∑
i∈I∗
αI∗,iK
(
x− xi
h
)
, (16)
where αI∗,i denotes the i-th weight obtained using the optimal
set I∗. The resulting mean-shift vector has the form
m
(SS-MS)
h,K′ (x) =
[∑
i∈I∗ αI∗,ixiK
′
(
x−xi
h
)∑
i∈I∗ αI∗,iK
′
(
x−xi
h
) − x] . (17)
A robust sparse formulation (RSS-MS) can be derived [10].
To solve Eq. (15), we need to: 1) find a solution for the inner
optimisation problem; i.e., solve for α: 2) find an optimal set
I∗. For a fixed I, αI = Ξ−1I ξI . Here
ΞI = (〈Φ(xi),Φ(xj)〉)i,j∈I (18)
ξI =
L∑
j=1
wj〈Φ(xm),Φ(xj)〉,m ∈ I, (19)
where ΞI is the Gram matrix. To ensure convergence,
αi < 0, ∀i = 1, ..., N . Generally, αi will not always fulfill the
property. We, therefore, normalise the weights αi by setting
to zero all weights αi < 0 and re-normalising such that∑
i αi = 1. The optimal index subset is found by assuming a
fixed N and maximising an incoherence function νI
I∗ = max
I⊆{1,...,L}
νI , (20)
6where
νI = min
j /∈I
max
i∈I
〈Φ(xi),Φ(xj)〉. (21)
This is intuitive in the sense that to find the most representative
subset of data vectors, we choose the ones that are most
incoherent to each other. In [10], we outline an algorithm to
maximize νI and determine I∗. The question remaining is
how to choose the cardinality N of the subset of indices I.
Clearly, in some cases this can be given by the application
at hand knowing a certain Nmax, or by using test data for
cross-validation, as in [10], where N is set to be sufficiently
high to incorporate the worst-case scenario. We introduce a
data-driven selection of N , which results in a smaller N for
most data sets than cross-validation. Figure 6 shows typical
examples of the progression of a normalised version of νI
ν˜I =
νI,|I|=N
max νI
(22)
for the images given in Fig. 3, using different values of
N = 1, . . . , L. We observe that the value of ν˜I drops quickly
after a certain value of N and that the behaviour of the curve
is similar for different images. This signifies that the first
Nν samples chosen by the algorithm contribute highly to the
incoherence in the image and it is sufficient to use a subset
I of cardinality Nν for the sparse representation. We propose
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Fig. 6: An example of the progression of normalised ν with
increasing cardinality N .
to choose Nν based on the gradient of ν˜I in Fig. 6 and set a
threshold Tν
∆ν˜(Nν) =
νI,|I|=Nν
νmax
−
νI,|I|=Nν−1
νmax
≤ Tν . (23)
The choice of Tν is based on heuristics and chosen specifically
for the data at hand by observing the trade-off between
accuracy and computation.
4) Convergence Properties of the Derived Algorithms:
It remains to prove that the mean-shift algorithm in all its
variations will converge. In [19], the convergence proof of the
standard MS is given. We extend it for the cases of the R-MS
and the SS-MS.
Theorem 1. If wl > 0 holds for the weights from Eq. (10)
and the kernel function K(·) has a convex and monotonically
decreasing profile, the sequence of trajectory points {x(j)},
j = 1, 2, . . . will converge and the sequence {fˆK
(
x
(j)
)
},
j = 1, 2, . . . is monotonically increasing.
The proof given in Appendix A is a generalised version of
Theorem 1 in [19]. We need to ensure that the weights will
fulfill wR-MSl > 0 for R-MS and αI∗,i > 0 for SS-MS. wR-MSl
are derived using the IRWLS and are, thus, certain to follow
the required property for monotone loss functions ρ(·) . The
calculation of αI∗,i ensured that it follows this property.
D. Segmentation Using the Medoid-Shift Algorithm
The medoid-shift was derived by Sheikh et al. in [23] as an
alternative to the mean-shift that uses the medoid instead of
the mean. The medoid is defined as the point in the set that
has the smallest distance to all other points. We derive here a
robust medoid-shift and a sparse scalable medoid-shift. This
results in the following formulation for successive locations
of x:
x
(j+1) = argmin
x∈{xl}
L∑
l=1
∣∣∣∣∣∣x− xl∣∣∣∣∣∣2wlK ′(x(j) − xl
h
)
, (24)
where wl represents the weights associated with each kernel.
For the standard medoid shift (MedS) wl = 1L and for the
robust medoid-shift (R-MedS) wl = wR-MSl . For the sparse
scalable medoid-shift
x
(j+1),SS-MedS = argmin
x∈{xi}
∑
i∈I∗
∣∣∣∣∣∣x− xi∣∣∣∣∣∣2× (25)
αI∗,iK
′
(
x
(j) − xi
h
)
Unlike the mean-shift, the medoid-shift always converges to
points contained in the data set. The advantage of this is
that the medoid-shift vector needs only to be computed once
for every data sample and hence, needs less iterations than
the mean-shift. Moreover, it does not need a further heuristic
like the mean-shift to group together neighbouring clusters.
The convergence of the sequence of trajectory points in the
medoid-shift is guaranteed and the proof is analogous to that
of the mean-shift. The only difference is that for the medoid-
shift we additionally need to ensure that there are no cycles
in the sequence of trajectory points, i.e., x(j) 6= x(j+c), for all
c > 0. The proof thereof is given in Appendix B.
E. Cluster Assignment
The segmentation leaves us with a finite number of cluster
centres corresponding to the different image regions. Typically,
we attain 2 − 4 clusters; 1) one corresponding to the ROI,
2) another to the dry test strip area and optionally 3) one
to the border between the dry area and the ROI, and 4) one
corresponding to artefacts in the image. We need to identify
which cluster center corresponds to the ROI. This can be done
using a data-driven approach, exploiting information from the
structure of the images. Using the size of the clusters, we can
identify the background region and the ROI, as they are the
largest. The ROI will correspond to the one exhibiting the
lower intensity of the two remaining regions according to the
nature of the chemical reaction.
7F. Convergence Test
Convergence of the chemical reaction is a very crucial
issue for the estimation accuracy. Ideally, the chemical kinetic
curve evolves as in Fig. 2. Final convergence is typically
reached after 10 sto15 s. This leads to a long measurement
time for the patient and, hereby, reduced usability, which can
be a cause of irregular self-control. So far, the convergence
of kinetic curves in hand-held devices has been defined as
the point at which the slope of the kinetic curve reaches a
threshold Tslope over a predefined time period [5]. This point
is reached after around 3 sto15 s, depending on the underlying
measurement. The assumption made, hereby, is that in the ideal
case, measurements of equal glucose concentration will follow
a similar progression at all times and, therefore, the intensity
value estimate at the predefined slope threshold will be related
to the underlying glucose concentration. The mapping function
between intensity and glucose can be adjusted to account
for the inaccuracy. While this can lead to satisfactory results
when no information is given on the kinetic curve, we will
show that it can also result in erroneous, premature estimates.
We propose to improve the performance of this approach
drastically by incorporating a model of the kinetic behaviour
of the chemical reaction [7], along with state estimation
techniques to predict the actual convergence values ahead of
time. Hereby, stages 2) and 3) of the kinetic curve depicted in
Fig. 2 are modelled.
The glucose oxidase taking place on the chemical test strip
can be modelled by the differential equation [7]
r(n) = (rD − rC) · e
−nτ + rC + v(n), n > nD, (26)
where r(n) is the remission measurement value at time n,
r0 is the initial remission value after the drop, and rC is the
convergence value of the relative remission after the chemical
reaction has converged. We define rC to be the state that we
want to predict. Furthermore, τ is the reaction rate, and v(n)
is a zero-mean, white, Gaussian noise process with unknown
variance σ2v describing the measurement noise.
Due to the nature of the chemical reaction, it is realistic to
assume that τ and rC are correlated. Building up on [7], we
perform a regression analysis using a real data set of estimated
convergence values rˆC = [rˆC,1, ..., rˆC,NM ] and corresponding
rates τˆ = [τˆ1, ..., τˆNM ], NM being the number of available
measurements. Hereby, we establish a linear relation between
τ and rC to be the most suitable least-squares (LS) fit, as can
be seen in Fig. 7
τˆ = ∆τ · rˆC + τ0, (27)
where ∆τ > 0 and τ0 < 0. Using a least-squares (LS) fit, we
estimate the regression parameters ∆τ and τ0, to obtain from
Eq. (26) the following nonlinear relation for the kinetic curve
r(n) = (rD − rC) · e
−n·(∆τ ·rC+τ0) + rC + v(n) (28)
= f(rC , v(n)) , n > nD.
We use an Extended Kalman Filter (EKF) to process the
measured kinetic curve and perform an online prediction of
the remission convergence value rC . For that, we formulate
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Fig. 7: Regression analysis for the relation between τ and rC
the prediction and measurement equations as follows
rˆC(n) = a(n)rˆC(n− 1) + w(n) (29)
rˆ(n) = h(rˆC(n), v(n)) , (30)
where a(n) is the transition matrix describing the transition
of the state estimate rˆC from time n − 1 to n. In our case,
a(n) = 1, as rC is a static state of the chemical reaction.
The process noise is modelled by the random variable w(n)
and can be used to account for uncertainty in the model.
h(rˆC(n), v(n)) describes the observation model, relating the
estimated state rˆC(n) to the measurement rˆ(n). It is given by
the partial derivative of the process model w.r.t. the state rˆC
h(rˆC(n), v(n)) =
∂f(rˆC(n), V (n))
∂rˆC(n)
(31)
= 1− e−n·(∆τ ·rˆC(n)+τ0)
× (1 + rD ·∆τ · n− rˆC(n) ·∆τ · n) .
We alternate between the prediction and the correction step of
the EKF, including a new measurement rˆ(n) in each iteration.
G. Mapping to Glucose Concentration
Finally, we map the relative remission estimate rˆC to the
underlying glucose concentration, which we will deliver to
the user. To this end, a calibration function fCalib : rˆC → gˆ
is coded into the glucometer to perform the mapping during
measurement. The calibration function has to be generated
a priori by means of photometric measurements performed
under lab conditions, using blood samples with known under-
lying glucose concentrations.
IV. EXPERIMENTAL RESULTS AND DISCUSSION
A. Data Sets
TABLE I: The real data sets used for validation.
Set NM Ng Υ Volume
A 48 5 6.45 µm/ Pixel 10 nl to 100 nl
B 78 16 6.45 µm/ Pixel 10 nl to 100 nl
C 78 16 6.45 µm/ Pixel 10 nl to 100 nl
D 48 4 30 µm/ Pixel 10 nl to 100 nl
E 200 10 30 µm/ Pixel around 1 nl
F 200 10 30 µm/ Pixel Standard
8To evaluate our proposed framework, we use real data sets,
obtained from a setup as in Fig. 1 using blood samples from
blood donations injected with a glucose solution corresponding
to the amount of glucose needed. Altogether, we have six
different data sets, comprising 452 different measurements
which corresponds to a total of 263.064 processed images.
The sets differ in terms of the chemical used as well as
the resolution of the camera and the volume of the blood
sample. This results in a different blood flow over the test
strip and thereby different positions and shapes of the region
of interest, as well as prominence of the reaction. Information
on the different data sets is given in Table I. The number of
measurements in the data sets is denoted by NM , the number
of different glucose concentrations tested in each data set
by Ng , and the resolution of the images by Υ. The volume
of the blood drop ”Standard” indicates state-of-the-art ranges
around 1 µlto25 µl [6]. Each measurement contains Nf = 580
frames obtained at a frame rate of fs = 30 fps. All data
sets are pre-processed applying a binning size of B = 5
for Υ = 6.45 µm /Pixel and B = 1 for Υ = 30 µm/Pixel.
After binning, all images contain L = 1210 pixels. For the
KDE, a Gaussian kernel and a fixed bandwidth parameter h
as in [8] are employed. Tslope is chosen to be 10−2. For the
robust versions, as in [9], Huber’s loss function is used and its
parameter tuned to achieve 95% asymptotic efficiency in the
Gaussian case; IRWLS is initialised with uniform weights.
B. Validation Methods
1) Coefficient of Variation: The coefficient of variation
(CV) is a very popular measure to assess the accuracy of
pharmacokinetic measurements [31]. In our work, we use the
remission coefficient of variation CVrˆ
CVrˆ =
1
Ng
Ng∑
γ=1
CVrˆg(γ) , CVrˆg(γ) =
σˆRˆg(γ)
µˆRˆg(γ)
(32)
where γ = 1, . . . , Ng , σˆRˆg(γ) and µˆRg(γ) are the sample
standard deviation, and respectively the sample mean of the
elements of the set Rˆg(γ). Rˆg(γ) denotes the test set of relative
remission estimates obtained from several measurements of the
same underlying glucose concentration g(γ).
2) The Clarke Error Grid: The Clarke Error Grid (CEG)
[32] is a standard method for evaluating glucose measurement
performance. It plots the estimated glucose concentrations
against the actual glucose concentrations and classifies the
error according to its medical severity. To this end, different
regions are defined in the CEG as depicted in Fig. 13. A
common specification is to have at least 95% of all points
in the region A, maximally 5% of all points in the region B
[33] and no points in the other zones.
3) The Glucose-Specific Mean Absolute Deviation: To
quantify the validation, we employ a glucose specific mean
absolute deviation (MAD) inspired by [32]. Instead of using
the standard MAD between the true and the estimated glucose
level, a glucose-specific MAD (gMAD) is defined. The gMAD
weighs the errors using a penalty function according to their
medical severity on the basis of the CEG. Hereby, errors made
for hypoglycaemic cases below 70mg/dl are weighed with the
highest factor wgMAD as they present critical short-term risks;
hyperglycaemic cases which present more long-term risks are
weighed with a slightly smaller factor wgMAD, and normal
cases are given the factor wgMAD = 1. The gMAD reads
gMAD = 1
N
NM∑
γ=1
∣∣∣g(γ)− ˆg(γ)∣∣∣ · wgMAD(g(γ)− ˆg(γ)), (33)
where the penalty function is given by
wgMAD(g − gˆ) =

1.5σ(g)σ(gˆ) if g ≤ 85 and gˆ ≥ g;
1σ(g)σ(gˆ) if g ≥ 155 and gˆ ≤ g;
1 otherwise,
(34)
with σ(·) and σ(·) being sigmoid functions that ensure a
smooth transition as given in [32]. According to the most
recent ISO standards [34], the maximal permissible error is
±15mg/dl within a reference range of 0mg/dlto75mg/dl and
20% for a reference range above 75mg/dl.
C. Results
First, we analyze the quality of the remission results. Herein,
a comparison of the segmentation methods is given, as well
as an analysis of the different data sets. Next, we evaluate
the data-driven choice of Nν for the SS-MS. We, then, turn
our attention to the effect of using the EKF to predict the
convergence estimates. Finally, we study the precision of the
glucose estimates after the mapping operation.
1) Kinetic Curves & Remission Accuracy: In Fig. 8, we
present a selection of the results of the kinetic curves, i.e.,
the progression of the relative remission over time for the
different data sets, using MS (mean-shift), RSS-MS (robust
sparse MS), MedS (medoid-shift), and R-MedS (robust MedS).
For the time being, we will present the results using the
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(c) Set E using MedS
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(d) Set F using R-MedS
Fig. 8: Kinetic curves for different Sets using the different
variants of MS and MedS. The red circles signify convergence
points rˆ(Stand. Conv)C .
standard convergence criterion, i.e., when the slope reaches a
9TABLE II: CVrˆ values for the different data sets using the standard convergence criterion.
.
Set MS R-MS MedS R-MedS SS-MS RSS-MS SS-MedS RSS-
MedS
A 1.59 1.29 1.17 1.22 1.87 1.81 1.52 1.52
B 1.95 1.83 1.82 1.71 2.4 2.1 1.95 1.95
C 1.15 1.51 0.90 0.99 1.50 1.41 1.39 1.39
D 1.87 1.7 1.58 1.39 1.87 2.90 1.10 1.09
E 3.98 4.17 3.39 3.25 5.9 5.6 4.3 4.2
F 1.48 1.37 1.10 1.04 2.44 2.25 1.99 1.78
threshold of Tslope for a series of consecutive frames. Overall,
we establish the expected progression of the kinetic curve with
its three typical stages as in Fig. 2. We see that measurements
of the same underlying glucose concentration are, mostly, bun-
dled together. Convergence is reached faster for low glucose
concentrations than for high glucose concentrations. Moreover,
our assumption that the decay rate τ of the reaction is corre-
lated with the underlying glucose concentration is confirmed.
The higher the underlying glucose concentration, the steeper
the decay.
We observe a significant decrease in performance when com-
paring Set E with Set F, which were taken using the exact same
setup and blood samples, however using different volumes
of the blood samples. These results are underlined when
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Fig. 9: Histograms of converged images of high glucose range
measurements from (a) Set B, (b) Set C.
analyzing the resulting CVrˆ values for these two sets in the
left part of Table II. This indicates that blood sample volumes
in the range of 1 nl could be problematic. The volume range
10 nlto100 nl, in contrast, seems to perform well.
Table II shows that the medoid-shift versions are significantly
better than the mean-shift versions for all sets. Observing Set
B, we notice that the difference in performance between the
two methods is not as high as for other sets. The reason can be
understood from Fig. 9. The more distinct the modes are, the
more separable the clusters, the better mean-shift performs.
By choosing the medoid instead of the mean and converging
to actual points in the data set, the medoid-shift doesn’t show
this bias in estimators.
The results for the sparse scalable mean-shift are given in
the right part of Table II. We assert that the resulting CVrˆ
values are slightly worse than their non-scalable counterparts.
This degradation, however, is not too severe and the loss in
accuracy can be accepted to ensure lower computation. Only
for Set E do we notice a severe degradation in performance,
when using the SS-MS. This can be traced back to the fact
that due to the very small blood volume, the ROI is much
smaller than for the other measurements.
2) Data-driven Choice of Nν for the Sparse MS: As
portrayed in Section III-C3, we propose a data-driven approach
to select Nν uniquely for every frame. Figure. 10 shows the
choice of Nν for Set C, with Nν averaged over all frames for
each measurement. The tendency matches our expectations:
very low glucose concentrations are characterized by low
contrast and therefore higher coherence. The choice of Nν is
higher than for high glucose concentrations, i.e., more data
points are needed to reliably represent the image. As the
concentration increases and the images become more distinct
in the different regions, the variance in the choice of Nν for
the same glucose concentrations decreases. Taking the worst-
case scenario would have resulted in N ≈ 370 data points,
which is much higher than the data-driven choice of N .
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Fig. 10: The choice of Nν for different glucose concentrations
for Set C.
Let us now analyze the quality of the SS-MS when using
a data-driven choice of Nν versus a fixed Nν = 0.37L. The
results are given for the RSS-MedS in Table. III. Evidently, the
accuracy of both approaches is comparable. This underlines
that a data-driven Nν maintains the accuracy needed.
TABLE III: Comparison of the CVrˆ values for a data-driven
choice of Nν vs. a fixed Nν = 0.37L.
Choice of Nν A B C D E F
Data-driven 1.03 1.29 0.81 1.90 4.60 1.59
Fixed 0.95 1.38 1.27 1.97 4.35 1.64
3) State Estimation using the EKF: The kinetic curves in
Fig. 8 show that convergence for same-glucose-level measure-
10
ments is not always reached at the same time which results
in strongly varying remission estimates, although the course
of the kinetic curve is very similar. Let us take the 550mg/dl
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Fig. 11: (a) State estimation of rC using the EKF. The red
circles (◦) indicate the estimated convergence values. (b) A
comparison of the convergence estimates using the standard
convergence criterion and the EKF.
measurements in Fig. 8 (b) as an example. Convergence is
found at times between tˆC ≈ 4 s and tˆC ≈ 9 s, leading
to remission estimates from rˆC ≈ 50% to rˆC ≈ 59%.
Figure 11 (a) shows the EKF state estimates rˆ(EKF Conv)C for
this example. Evidently, the EKF converges to reliable state
estimates quickly and therefore, the resulting rˆC estimates not
only lie in the same range, but match the final convergence
value of the kinetic behavior more accurately. This can be seen
clearly in Fig. 11 (b). The convergence value reached by the
standard method rˆ(Stand. Conv)C occurs after around 11 s and does
not match the actual saturation value. The convergence value
reached by EKF rˆ(EKF Conv)C , however, occurs after 5 s and is
much closer to the actual saturation value.
TABLE IV: Time gain and reduced error obtained using EKF.
Time Gain Error Benefit
Low Glucose Range (g ≤ 75mg/dl) 1.41 s 2.23 %
High Glucose Range (g > 75mg/dl) 0.97 s 2.1 %
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Fig. 12: (a) Comparison of the CVrˆ values for the standard
convergence criterion to EKF. (b) Comparison of the gMAD
values for the standard convergence criterion to EKF.
Table IV shows the time gain obtained using the EKF. These
results are the average of all time gain values obtained for all
sets over all measurements. Comparing the remission estimates
rˆ
(Stand. Conv)
C and rˆ
(EKF Conv)
C to the saturation values of the
chemical reaction, we assert that the EKF produces more
accurate results, with a gain of more than 2% in remission.
Figure 12 presents a comparison of CVrˆ values and gMAD
values for the standard convergence criterion and the EKF
convergence method. This analysis considers for each set the
method with the best results in Tables II and V, respectively,
and compares it to its EKF-method-equivalent. The EKF
convergence always leads to improved CVrˆ values. Similarly,
for the high glucose range the gMAD results show the same
outcome. For low glucose ranges the standard convergence
compares favourably. The reason for this is that the EKF
method is quite sensitive to the model used. As can be seen
in Fig. 8, the kinetic curves of low glucose measurements
exhibit a dip after the drop followed by a steady rise. This is
not embodied in the model in Eq. (28).
4) Mapping to the Underlying Glucose Concentrations:
Finally, we present the results of the glucose estimates gˆ
obtained by mapping the remission estimates using fCalib. The
(a) (b)
Fig. 13: Clarke’s Error Grid Analysis for Set E for (a) the
standard and (b) the EKF convergence criteria.
Clarke Error Grid plot of Set E in Fig. 13 (a) shows that 93 %
of the points lie in region A, 6 % lie in region B and 1% lie
in region D using the standard convergence criterion. Thereby,
the results do not conform with the requirements. As indicated
by the results in Fig. 13 (b), using EKF state estimation to
predict the convergence values leads to a significant improve-
ment of the results. Now 100% of the estimates of Set E lie
in the A-region. Table V presents the mean gMAD values
Low Glucose (≤ 75mg/dl) High Glucose (> 75mg/dl)
Set MS R-
MS
MedS R-
MedS
MS R-
MS
MedS R-
MedS
B 14.4 13.0 6.6 6.6 13.4 11.8 17.0 17.2
C 6.9 6.9 4.6 4.0 12.8 14.4 7.8 8.9
E 22.6 29.4 24.4 21.0 30.8 37.4 25.5 23.6
F 9.3 9.4 8.5 8.1 17.5 17.0 16.6 18.4
TABLE V: gMAD values using the standard convergence
criterion.
.
for gˆ of each set separated according to the glucose range.
This analysis is omitted for Sets A and D, as they do not
contain enough different glucose concentrations to construct
the mapping function. The results for most sets lie below the
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ISO requirements, i.e., low glucose ranges show errors smaller
than gMAD = ±15mg/dl and high glucose ranges show an
error larger than 20%. However, we note that in Set E the
limit is often exceeded, confirming again the fact that blood
sample volumes around 1 nl are problematic.
The previously made observation concerning medoid-shift
outperforming mean-shift is confirmed again here. The robust
version seems to improve the performance in high glucose
ranges more than in low glucose ranges.
V. CONCLUSION
Regular self-control using hand-held glucometers is an
indispensable part of diabetes care and therefore, glucometers
should maintain high accuracy while improving usability. We
have developed a full framework to measure the blood glu-
cose concentration from glucose images using blood sample
volumes in the nl-range, which is much smaller than the
state-of-the-art, while complying with the most recent ISO
standards for accuracy [34]. Using the mean-shift principle
and its variations, the robust and scalable sparse mean-shift,
the intensity level of the region of interest is estimated. We
have shown that the scalable version of the mean-shift with
an individual selection of the number of data points gives
good results w.r.t. accuracy, while decreasing the computation
time. These variations are extended to the medoid-shift, which
outperforms the mean-shift in our experiments. Furthermore,
the convergence of all mean-shift and medoid-shift variations
is proven. We assert that the mean-shift and its variations
are suitable for segmentation applications, where the number
and size of the regions is unknown. The extended Kalman
filter and a model for the chemical reaction are employed
to enhance the accuracy of the estimate and reduce the
measurement time by around 20%. A linear relation has been
found between the convergence of the glucose reaction and
its decay rate. We establish that inaccuracies in the derived
model can lead to degraded performance and, therefore, the
model has to be calibrated uniquely for each specific setup
used. As future work, we aim to enhance this model, taking
into account not only the underlying glucose concentration but
also incorporating affecting parameters such as temperature,
humidity, and the haematocrit level [12] and viscosity of the
sample. Additionally, we see the need to further validate our
framework with clinical tests. Finally, we establish that very
low blood sample volumes of 1 nl seem to be at the limit of
what is acceptable in accuracy.
APPENDIX A
PROOF OF CONVERGENCE OF THE MEAN-SHIFT
ALGORITHM WITH WEIGHTS wl
Proof. Since L is finite, the sequence {fˆK
(
x
(j)
)
},
j = 1, 2, . . . is bounded. We will show that for x(j) 6= x(j+1):
fˆK
(
x
(j)
)
< fˆK
(
x
(j+1)
)
. Without loss of generality we
assume x(j) = 0, k being the profile of the kernel K(·) [19]
fˆK
(
x
(j+1)
)
− fˆK
(
x
(j)
)
=
1
h
L∑
l=1
wl (35)
×
[
k
(
x
(j+1) − xl
h
)
− k
(xl
h
) ]
For convex profiles and x2 6= x1, x1, x2 ∈ [0,∞) it follows
k(x2) ≥ k(x1) + k′(x1) (x2 − x1), such that
fˆK
(
x
(j+1)
)
− fˆK
(
x
(j)
)
≥ −
1
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L∑
l=1
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′
(xl
h
)
· (36)
×
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||xl||
2 −
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= −2
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h
)
+
1
h
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= −
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Since k(x) is monotonically decreasing, −k′(x) ≥ 0 for x ∈
[0,∞).
∑L
l=1−k
′
(
xl
h
)
is strictly positive, as are the weights
wl. Hence fˆK
(
x
(j+1)
)
− fˆK
(
x
(j)
)
> 0 and the sequence
{fˆK
(
x
(j)
)
} is convergent.
Without assuming x(j) = 0 and reformulating (35) we get
fˆK
(
x
(j+1)
)
− fˆK
(
x
(j)
)
≥ (37)
= −
1
h
L∑
l=1
wl
∣∣∣∣∣∣x(j+1) − x(j)∣∣∣∣∣∣2 · k′(x(j) − xl
h
)
.
Since fˆK
(
x
(j+1)
)
− fˆK
(
x
(j)
)
converges to zero, then∣∣∣∣x(j+1) − x(j)∣∣∣∣2 also converges to zero and x(j),j = 1, 2, . . .
is a Cauchy sequence.
APPENDIX B
EXTENSION OF THE PROOF OF CONVERGENCE FOR THE
MEDOID-SHIFT WITH WEIGHTS wl
Proof. The choice of successive points in the medoid-shift
algorithm, as given in (24), is carried out according to
L∑
l=1
1
h
∣∣∣∣∣∣x(j) − xl∣∣∣∣∣∣2wlk′(x(j) − xl
h
)
(38)
>
L∑
l=1
1
h
∣∣∣∣∣∣x(j+1) − xl∣∣∣∣∣∣2wlk′(x(j) − xl
h
)
,
as equality of these two terms indicates convergence. This can
be reformulated as
L∑
l=1
1
h
wlk
′
(
x
(j) − xl
h
)
(39)
×
[∣∣∣∣∣∣x(j) − xl∣∣∣∣∣∣2 − ∣∣∣∣∣∣x(j+1) − xl∣∣∣∣∣∣2]
= −
L∑
l=1
1
h
wl
∣∣∣∣∣∣x(j+1) − x(j)∣∣∣∣∣∣2k′(x(j) − xl
h
)
> 0,
proving that fˆK
(
x
(j+1)
)
> fˆK
(
x
(j)
)
, hence that the
sequence {fˆK
(
x
(j)
)
}, j = 1, 2, · · · is strictly positive and
thus x(j) 6= x(j+c), for all c > 0. This proves that their are
no cycles and medoid-shift will converge.
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